BioCryst Pharma Balance Sheet - Quarterly (NASDAQ:BCRX)

Add to My Stocks
$7.31 $0.02 (0.27%) BCRX stock closing price Sep 20, 2018 (Closing)

The financial analysis of a company like BioCryst Pharma involves checking the three financial statements of the company in detail, of which the balance sheet is one. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our BioCryst Pharma stock analysis. Quarterly results are typically accompanied with the company releasing financial statements. The BioCryst Pharma balance sheet for 2018 Q2 shows total assets of $136.64M. The company has a asset turnover ratio of 0.34. Also see: BioCryst Pharma revenue and BioCryst Pharma operating cash flow for the same quarter.

View and download BioCryst Pharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Cash34.73M48.36M53.56M120.89M45.05M77.95M23.65M36.89M13.08M14.86M
Marketable Securities53.64M47.54M64.11M43.84M40.97M23.52M32.54M17.43M27.07M22.91M
Receivables2.34M5.69M6.11M8.98M3.32M9.56M8.76M5.96M2.23M7.38M
Inventory----1.3M--2.23M1.94M1.94M
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets1.74M2.54M1.59M1.63M1.6M1.8M1.52M2.1M1.76M3.31M
Total Current Assets
92.67M104.15M125.39M175.37M92.26M113.5M66.98M64.63M46.11M50.42M
Property Plant & Equipment--14.87M---14.83M---
Accumulated Depreciation--5.32M---4.91M---
Net Property Plant & Equipment
9.39M9.39M9.54M9.61M9.6M9.75M9.92M10.09M10.11M8.36M
Investment & Advances33.74M41.59M41.29M4.53M9.6M3.8M8.92M14.37M24.15M41.13M
Other Non-Current Assets----------
Deferred Charges----------
Intangibles----------
Deposits & Other Assets--2.02M1.95M1.87M2.27M3.81M2.19M1.61M2.71M
Total Assets
136.64M155.37M178.25M191.49M113.5M129.51M89.84M91.5M82.21M102.88M
Notes Payable28.9M28.68M28.24M30M30M-----
Accounts Payable4.12M3.58M6.33M4.6M1.84M5.43M4.26M2.76M5.05M7.69M
Current Portion Long-Term Debt6.53M6.49M6.46M4.72M2.99M1.27M----
Current Portion Capital Leases----------
Accrued Expenses19.41M15.62M12.69M11.87M12.32M11.33M10.83M10.78M11.78M17.32M
Income Taxes Payable----------
Other Current Liabilities15.13M20.76M20.57M19.39M13.3M12.16M11.01M9.84M11.33M10.13M
Total Current Liabilities
74.17M75.34M74.83M69.23M58.93M58.55M54.36M51.52M56.19M63.07M
Mortgages----------
Deferred Taxes/Income----7.79M8.11M8.42M8.74M9.07M9.5M
Convertible Debt----------
Long-Term Debt13.47M15.11M16.75M18.37M19.99M21.61M22.77M22.66M--
Non-Current Capital Leases2.71M2.73M2.75M2.77M2.7M2.7M2.7M2.67M2.58M2.5M
Other Long-Term Liabilities-------1.9M--
Total Liabilities
90.46M93.31M94.49M90.86M89.43M90.98M88.26M87.5M68.83M75.08M
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus720.59M718.03M714.86M711.96M620.45M618M566.91M564.79M562.63M560.76M
Retained Earnings-674.94M-656.49M-631.84M-612.3M-597.16M-580.28M-566.06M-561.55M-550.03M-533.74M
Treasury Stock----------
Other Liabilities-0.45M-0.47M-0.24M-0.01M-0.01M--0.01M---
Shareholders Equity46.18M62.05M83.76M100.63M24.07M38.53M1.57M3.99M13.38M27.79M
Total Liabilities & Shareholders Equity136.64M155.37M178.25M191.49M113.5M129.51M89.84M91.5M82.21M102.88M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Click here to view our BioCryst Pharma financial analysis

The latest BioCryst Pharma stock price, and BioCryst Pharma historical stock prices show the stock price movement over time, and the BioCryst Pharma PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:

  • Assets: An asset is a resource that a corporation like BioCryst Pharma owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for BCRX stock as of 2018 Q2 is $136.64M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. BCRX stock had total liabilities of $90.46M for the quarter 2018 Q2.

BioCryst Pharma Balance Sheet - Key Ratios

Current ratio
1.25
Debt to equity ratio
1.12
Asset turnover ratio
0.34
Receivables turnover
5.51
Price to book ratio
11.4